Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
-
* Corresponding author: Anne E Lykkesfeldt al@cancer.dk
Breast Cancer Research 2009, 11:R11 doi:10.1186/bcr2230
Accesses
- Last 30 days: 57 accesses
- Last year: 869 accesses
- All time: 4346 accesses
Cited by
BioMed Central: 2 citations
|
Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer Isabel F Pinhel, Fiona A MacNeill, Margaret J Hills, Janine Salter, Simone Detre, Roger A'Hern, Ashutosh Nerurkar, Peter Osin, Ian E Smith, Mitch Dowsett Breast Cancer Research 2010, 12:R76 (28 September 2010) |
|
Ramaswamy Bhuvaneswari, Yik Gan, Khee Soo, Malini Olivo Molecular Cancer 2009, 8:94 (2 November 2009) |